Cargando…

Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy

The eradication therapy of Helicobacter pylori (H. pylori) infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. Culture from biopsies is maybe the most used method among the antimicro...

Descripción completa

Detalles Bibliográficos
Autores principales: Manfredi, Marco, Gismondi, Pierpacifico, Maffini, Valentina, Bizzarri, Barbara, Fornaroli, Fabiola, Madia, Carmen, Salerno, Antonino, Cangelosi, A. Marta, de'Angelis, Gian Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438156/
https://www.ncbi.nlm.nih.gov/pubmed/26064096
http://dx.doi.org/10.1155/2015/717349
_version_ 1782372285516087296
author Manfredi, Marco
Gismondi, Pierpacifico
Maffini, Valentina
Bizzarri, Barbara
Fornaroli, Fabiola
Madia, Carmen
Salerno, Antonino
Cangelosi, A. Marta
de'Angelis, Gian Luigi
author_facet Manfredi, Marco
Gismondi, Pierpacifico
Maffini, Valentina
Bizzarri, Barbara
Fornaroli, Fabiola
Madia, Carmen
Salerno, Antonino
Cangelosi, A. Marta
de'Angelis, Gian Luigi
author_sort Manfredi, Marco
collection PubMed
description The eradication therapy of Helicobacter pylori (H. pylori) infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. Culture from biopsies is maybe the most used method among the antimicrobial susceptibility techniques. In this study, we compared the antimicrobial susceptibility changes in children with H. pylori infection over 13 years and we confirmed that clarithromycin resistance has been increased (16% versus 26%) though with no statistically signficant value. Therefore, clarithromycin should not be used in empiric treatment of H. pylori eradication therapy in children, but its use should be limited only to children with known antimicrobial susceptibility. On the other hand, metronidazole resistance has decreased over this time period in statistically significant manner (56% versus 33%, p = 0.014). Furthermore, ampicillin resistance has been confirmed to be very rare (3% versus 0%) in children with H. pylori infection. In conclusion, in H. pylori infection, if we do not know the antibiotic susceptibility of patients, we should recommend an eradication therapy based on the local distribution of antibiotic resistance rates trying to limit the therapeutic failures.
format Online
Article
Text
id pubmed-4438156
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-44381562015-06-10 Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy Manfredi, Marco Gismondi, Pierpacifico Maffini, Valentina Bizzarri, Barbara Fornaroli, Fabiola Madia, Carmen Salerno, Antonino Cangelosi, A. Marta de'Angelis, Gian Luigi Gastroenterol Res Pract Research Article The eradication therapy of Helicobacter pylori (H. pylori) infection is still a challenge for gastroenterologists. One of the main causes of failure in H. pylori eradication is the antibiotic resistance mainly to clarithromycin. Culture from biopsies is maybe the most used method among the antimicrobial susceptibility techniques. In this study, we compared the antimicrobial susceptibility changes in children with H. pylori infection over 13 years and we confirmed that clarithromycin resistance has been increased (16% versus 26%) though with no statistically signficant value. Therefore, clarithromycin should not be used in empiric treatment of H. pylori eradication therapy in children, but its use should be limited only to children with known antimicrobial susceptibility. On the other hand, metronidazole resistance has decreased over this time period in statistically significant manner (56% versus 33%, p = 0.014). Furthermore, ampicillin resistance has been confirmed to be very rare (3% versus 0%) in children with H. pylori infection. In conclusion, in H. pylori infection, if we do not know the antibiotic susceptibility of patients, we should recommend an eradication therapy based on the local distribution of antibiotic resistance rates trying to limit the therapeutic failures. Hindawi Publishing Corporation 2015 2015-05-06 /pmc/articles/PMC4438156/ /pubmed/26064096 http://dx.doi.org/10.1155/2015/717349 Text en Copyright © 2015 Marco Manfredi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Manfredi, Marco
Gismondi, Pierpacifico
Maffini, Valentina
Bizzarri, Barbara
Fornaroli, Fabiola
Madia, Carmen
Salerno, Antonino
Cangelosi, A. Marta
de'Angelis, Gian Luigi
Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
title Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
title_full Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
title_fullStr Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
title_full_unstemmed Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
title_short Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy
title_sort primary antimicrobial susceptibility changes in children with helicobacter pylori infection over 13 years in northern italy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438156/
https://www.ncbi.nlm.nih.gov/pubmed/26064096
http://dx.doi.org/10.1155/2015/717349
work_keys_str_mv AT manfredimarco primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT gismondipierpacifico primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT maffinivalentina primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT bizzarribarbara primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT fornarolifabiola primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT madiacarmen primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT salernoantonino primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT cangelosiamarta primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly
AT deangelisgianluigi primaryantimicrobialsusceptibilitychangesinchildrenwithhelicobacterpyloriinfectionover13yearsinnorthernitaly